Richárd Márkus

Intralymphatic allergen administration renders specific immunotherapy faster and safer: A randomized controlled trial

Gabriela Senti, Bettina M. Prinz Vavricka, Iris Erdmann et al. · Proceedings of the National Academy of Sciences · 2008 · 364 citations

Life Sciences, Immunology, Pharmacology +17

Estimation of Cachexia among Cancer Patients Based on Four Definitions

Kathleen M. Fox, John M. Brooks, Shravanthi R. Gandra et al. · Journal of Oncology · 2009 · 143 citations · Full text

Medicine, Oncology, Pharmacology +15

NCCN Biosimilars White Paper: Regulatory, Scientific, and Patient Safety Perspectives

Andrew D. Zelenetz, Islah Ahmed, Edward L. Braud et al. · Journal of the National Comprehensive Cancer Network · 2011 · 140 citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +17

Microbiology, safety, and pharmacokinetics of aztreonam lysinate for inhalation in patients with cystic fibrosis

Ronald L. Gibson, George Retsch‐Bogart, Christopher M. Oermann et al. · Pediatric Pulmonology · 2006 · 112 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Denosumab Treatment of Prostate Cancer With Bone Metastases and Increased Urine N-Telopeptide Levels After Therapy With Intravenous Bisphosphonates: Results of a Randomized Phase II Trial

Karim Fizazi, Linda D. Bosserman, Guozhi Gao et al. · The Journal of Urology · 2012 · 111 citations

Medicine, Pharmacology, Pharmacotherapy +17